share_log

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target

HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $8 Price Target

HC Wainwright & Co.重申买入Microbot Medical,维持8美元的目标股价
Benzinga ·  2023/06/06 09:54

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $8 price target.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱重申Microbot Medical(纳斯达克股票代码:MBOT)的买入并维持8美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发